Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Setton J, Hadi K, Choo Z-, Kuchin KS, Tian H, Paula AD, et al. Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers. Nature. 2023;621(7977):129-137.

Ma C, Wang X, Dai JY, Turman C, Kraft P, Stopsack KH, et al. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study. Cancer Epidemiol Biomarkers Prev. 2023;32(10):1436-1443.

Vohra AS, Johannesen J, Jessurun J, Weinsaft JW, Singh HS, Cheung JW, et al. A mimicker of constriction: a case report of a rare case of cardiac angiosarcoma. Eur Heart J Case Rep. 2023;7(6):ytad260.

Toejing P, Sakunrangsit N, Pho-On P, Phetkong C, Leelahavanichkul A, Sridurongrit S, et al. Accelerated Bone Loss in Transgenic Mice Expressing Constitutively Active TGF-β Receptor Type I. Int J Mol Sci. 2023;24(13).

Utsumi T, Yamada Y, Diaz-Meco MT, Moscat J, Nakanishi Y. Sessile serrated lesions with dysplasia: is it possible to nip them in the bud? J Gastroenterol. 2023;58(8):705-717.

Singh B, Dopkins N, Fei T, Marston JL, Michael S, Reyes-Gopar H, et al. Locus specific human endogenous retroviruses reveal new lymphoma subtypes. bioRxiv. 2023.

Simner PJ, Bard JD, Doern C, J Johnson K, Westblade L, Yenokyan G, et al. Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures. Clin Infect Dis. 2023;76(9):1550-1558.

You J, Osea J, Mendoza S, Shiomi T, Gallego E, Pham B, et al. Automated and robust extraction of genomic DNA from various leftover blood samples. Anal Biochem. 2023;678:115271.

Stopsack KH, Su XA, J Vaselkiv B, Graff RE, Ebot EM, Pettersson A, et al. Transcriptomes of Prostate Cancer with TMPRSS2:ERG and Other ETS Fusions. Mol Cancer Res. 2023;21(1):14-23.

Li F, Wang Y, Hwang I, Jang J-, Xu L, Deng Z, et al. Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance. bioRxiv. 2023.